CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- 4 Planned sale EVP, General Counsel sold 1,000 shares at $347.27 ($347,270)
- 144 Insider Sale of Securities
- 4 Planned sale President, R&D sold 25,000 shares at an average $308.11 ($7,702,825)
- 4 Planned sale President and CEO sold 25,000 shares at an average $308.12 ($7,702,984)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Planned sale EVP, General Counsel sold 642 shares at $302.03 ($193,903)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Exhibits
- 10-Q Report Quarterly Report
- SCHEDULE 13G Stake Statement of Beneficial Ownership
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Planned sale President, R&D sold 25,000 shares at an average $263.21 ($6,580,270)
Page 2 of 26 · 513 filings